The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases

International Journal of Colorectal Disease

Volumn 29, Issue 1, 2014, Pages 9-14

  Schüle, Silke ^a   Neuhäuser, Claudia ^a   Rauchfuß, Falk ^a   Knösel, Thomas ^a,b   Settmacher, Utz ^a   Altendorf Hofmann, Annelore ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomarker; Colorectal; Desmocollin; Liver metastases; Prognosis

Indexed keywords

DESMOCOLLIN; DESMOCOLLIN 1; DESMOCOLLIN 3; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EPITHELIUM; FEMALE; HUMAN; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; TISSUE MICROARRAY; VERY ELDERLY;

AGED; COLORECTAL NEOPLASMS; DESMOCOLLINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; PERIOPERATIVE CARE; PROGNOSIS;

EID: 84891879479     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1765-y     Document Type: Article

References (21)

1. Settmacher U, Dittmar Y, Knosel T, Schone U, Heise M, Jandt K, Altendorf-Hofmann AK (2011) Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Color Dis 26(8):967-981. doi: 10.1007/s00384-011-1195-7
2. Jones RP, Jackson R, Dunne DF, Malik HZ, Fenwick SW, Poston GJ, Ghaneh P (2012) Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg 99(4):477-486. doi: 10.1002/bjs.8667
3. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309-318, discussion 318-321 (Pubitemid 30191861)
4. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77(7):1254-1262 (Pubitemid 26102322)
5. Hill CR, Chagpar RB, Callender GG, Brown RE, Gilbert JE, Martin RC 2nd, McMasters KM, Scoggins CR (2012) Recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol 19(1):139-144. doi: 10.1245/s10434-011-1921-y
6. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, Geller DA, Gayowski TJ, Fung JJ, Starzl TE (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189(3):291-299 (Pubitemid 29408866)
7. Gomez D, Cameron IC (2010) Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) 12(4):227-238. doi: 10.1111/j.1477-2574.2010.00158.x
8. Gregoire E, Hoti E, Gorden DL, de la Serna S, Pascal G, Azoulay D (2010) Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy. Eur J Surg Oncol 36(6):568-574. doi: 10.1016/j.ejso.2010.03.009
9. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, Nagorney DM (2007) Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246(2):183-191. doi: 10.1097/SLA.0b013e3180603039 (Pubitemid 47196514)
10. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole et, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007-1016. doi: 10.1016/S0140-6736(08)60455-9 (Pubitemid 351392040)
11. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL (2010) Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 17(2):492-501. doi: 10.1245/s10434-009-0781-1
12. Hamidov Z, Altendorf-Hofmann A, Chen Y, Settmacher U, Petersen I, Knosel T (2011) Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. J Clin Pathol 64(11):990-994. doi: 10.1136/jclinpath-2011-200099
13. Fang WK, Gu W, Li EM, Wu ZY, Shen ZY, Shen JH, Wu JY, Pan F, Lv Z, Xu XE, Huang Q, Xu LY (2010) Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor. Hum Pathol 41(10):1456-1465. doi: 10.1016/j.humpath.2010.04.003
14. Myklebust MP, Fluge O, Immervoll H, Skarstein A, Balteskard L, Bruland O, Dahl O (2012) Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. Br J Cancer 106(4):756-762. doi: 10.1038/bjc.2011.548
15. Rezze GG, Fregnani JH, Duprat J, Landman G (2011) Cell adhesion and communication proteins are differentially expressed in melanoma progression model. Hum Pathol 42(3):409-418. doi: 10.1016/j.humpath.2010.09.004
16. Anami K, Oue N, Noguchi T, Sakamoto N, Sentani K, Hayashi T, Hinoi T, Okajima M, Graff JM, Yasui W (2010) Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype. J Pathol 221(3):275-284. doi: 10.1002/path.2717
17. Cui T, Chen Y, Yang L, Knosel T, Zoller K, Huber O, Petersen I (2011) DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. Br J Cancer 104(6):1013-1019. doi: 10.1038/bjc.2011.28
18. Knösel T, Chen Y, Hotovy S, Settmacher U, Altendorf-Hofmann A, Petersen I (2012) Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma. Int J Color Dis. doi: 10.1007/s00384-012-1460-4
19. Knösel T, Emde A, Schluns K, Chen Y, Jurchott K, Krause M, Dietel M, Petersen I (2005) Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia 7(8):741-747
20. Knösel T, Emde V, Schluns K, Schlag PM, Dietel M, Petersen I (2006) Cytokeratin profiles identify diagnostic signatures in colorectal cancer using multiplex analysis of tissue microarrays. Cell Oncol 28(4):167-175 (Pubitemid 44427400)
21. Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, Cottier B, Poston G (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97(7):1110-1118. doi: 10.1002/bjs.7032